Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats

This publication has 36 references indexed in Scilit:

• Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models
  European Journal of Pharmacology, 1983
• Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions
  Life Sciences, 1983
• Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade
  Acta Pharmacologica et Toxicologica, 1982
• Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy
  European Journal of Pharmacology, 1982
• Effects of cholecystokinin octapeptide and its fragments on brain monoamines and plasma corticosterone
  Neurochemistry International, 1981
• Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in rats
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
• The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay
  Brain Research, 1981
• Schizophrenia as an inborn error in the degradation of β-endorphin — a hypothesis
  Trends in Neurosciences, 1979
• Neuroleptic activity of the neuropeptide β-LPH62–77 ([Des-Tyr1]γ-endorphin; DTγE)
  European Journal of Pharmacology, 1978
• Retention of a passive avoidance response as a function of the intensity and duration of electric shock
  Psychonomic Science, 1972